Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
AstraZeneca
Information provided by (Responsible Party):
Grace McComsey, University Hospitals of Cleveland
ClinicalTrials.gov Identifier:
NCT01218802
First received: October 8, 2010
Last updated: March 12, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
No publications provided by University Hospital Case Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):